Neurogene Income Statement (2013-2026) | NGNE

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Shares Outstanding (Entity) (Quarter)
2.75M2.75M2.75M2.76M2.76M2.76M2.76M2.77M2.81M2.78M0.49M
Revenue & cost
Revenue (Quarter)
0.93M
Operating items
Research & Development (Quarter)
9.82M9.90M9.76M10.70M10.96M9.47M16.38M10.28M10.32M11.61M12.18M13.54M15.74M16.29M15.35M17.76M19.37M17.24M20.64M25.15M
Selling, General & Administrative (Quarter)
5.30M5.56M5.41M4.66M4.92M4.14M-4.71M2.75M2.27M3.61M2.55M5.24M5.32M5.89M6.17M8.16M6.71M6.56M6.89M8.20M
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)
15.12M15.45M15.17M15.37M15.87M13.61M11.67M13.04M12.60M15.22M14.73M18.78M21.06M22.18M21.51M25.92M26.08M23.80M27.53M33.35M
Operating Income (Quarter)
-15.12M-15.45M-15.17M-15.37M-15.87M-13.61M-11.67M-13.04M-12.60M-15.22M-14.73M-18.78M-20.13M-22.18M-21.51M-25.92M-26.08M-23.80M-27.53M-33.35M
EBIT (Quarter)
-15.12M-15.45M-15.17M-15.37M-15.87M-13.61M-11.67M-13.04M-12.60M-15.22M-14.73M-18.78M-20.13M-22.18M-21.51M-25.92M-26.08M-23.80M-27.53M-33.35M
Non-operating items
Non Operating Investment Income (Quarter)
Interest & Investment Income (Quarter)
0.78M0.74M0.65M0.78M2.32M2.04M1.84M2.27M3.21M2.93M2.74M2.67M2.26M
Other Non Operating Income (Quarter)
16.36M0.14M0.14M0.14M0.14M0.15M1.21M0.15M0.16M0.16M
Non Operating Income (Quarter)
-0.01M0.00M0.00M-0.01M-0.02M-0.01M-0.01M19.28M1.86M1.64M1.96M2.00M3.27M4.07M2.85M2.79M2.42M
Net income details
EBT (Quarter)
-41.41M-33.83M-40.37M-15.39M-15.94M-13.70M-49.84M-12.26M-11.87M-14.57M-13.96M-48.66M-31.60M-40.34M-23.11M-23.41M-24.65M-23.96M-24.86M-38.29M
Tax Provisions (Quarter)
Profit After Tax (Quarter)
-15.13M-15.45M-15.17M-15.35M-15.69M-13.07M-49.84M-12.26M-11.86M-14.58M13.65M-16.92M-18.49M-20.22M-19.51M-22.65M-22.02M-20.95M-24.80M-30.93M
Income from Continuing Operations (Quarter)
-41.41M-33.83M-40.37M-15.39M-15.94M-13.70M-49.84M-12.26M-11.87M-14.57M-13.96M-48.66M-31.60M-40.34M-23.11M-23.41M-24.65M-23.96M-24.86M-38.29M
Consolidated Net Income (Quarter)
-41.41M-33.83M-40.37M-15.39M-15.94M-13.70M-49.84M-12.26M-11.87M-14.57M-13.96M-48.66M-31.60M-40.34M-23.11M-23.41M-24.65M-23.96M-24.86M-38.29M
Income towards Parent Company (Quarter)
-41.41M-33.83M-40.37M-15.39M-15.94M-13.70M-49.84M-12.26M-11.87M-14.57M-13.96M-48.66M-31.60M-40.34M-23.11M-23.41M-24.65M-23.96M-24.86M-38.29M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)
-41.41M-33.83M-40.37M-15.39M-15.94M-13.70M-49.84M-12.26M-11.87M-14.57M-13.96M-48.66M-31.60M-40.34M-23.11M-23.41M-24.65M-23.96M-24.86M-38.29M
Additional items
EPS (Basic) (Quarter)
-15.05-12.28-14.67-5.58-5.78-4.96-18.05-4.42-4.23-5.25-28.37-2.88-1.87-2.38-1.32-1.12-1.17-1.13-1.17-1.72
EPS (Diluted) (Quarter)
-15.05-12.28-14.67-5.58-5.78-4.96-18.05-4.42-4.23-5.25-3.00-2.88-1.87-2.38-1.32-1.12-1.17-1.13-1.17-1.72
Shares Outstanding (Quarter)
2.75M2.75M2.75M2.76M2.76M2.76M2.76M2.77M2.81M2.78M0.49M16.90M16.94M16.95M17.57M21.00M21.06M21.17M21.33M22.31M
Shares Outstanding (Diluted) (Quarter)
2.75M2.75M2.75M2.76M2.76M2.76M2.76M2.77M2.81M2.78M4.66M16.90M16.94M16.95M17.57M21.00M21.06M21.17M21.33M22.31M
EBITDA (Quarter)
-15.12M-15.45M-15.17M-15.37M-15.87M-13.61M-11.67M-13.04M-12.60M-15.22M-14.73M-18.78M-20.13M-22.18M-21.51M-25.92M-26.08M-23.80M-27.53M-33.35M
Interest Expenses (Quarter)
26.29M18.38M25.20M0.03M0.07M0.09M38.17M0.00M0.01M0.00M0.00M32.20M13.50M20.00M3.87M0.70M1.50M2.90M0.00M7.20M
Tax Rate (Quarter)